Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Your review * Everything happened in a timely manner start to finish
These data form the basis of our rolling Biologics License Application (BLA) with the FDA positioning MCO-010 to become the first FDA-approved optogenetic therapy for retinal disease
These findings compel further research to understand how mitochondrial metabolism and the related epigenetic programming of brain plasticity can serve as new targets to develop mechanism-based treatment models for psychiatric and neurodegenerative diseases
The neuroprotective actions of oestradiol and oestrogen receptors
Maximum dose: 15 mg subcutaneously once a week
As oestrogen levels fluctuate and eventually decline, many women may experience a shift in fat storage from the hips and thighs to the abdominal area, potentially increasing visceral fat
US$ 24.21
US$ 21.23
US$ 21.89
US$ 21.51
US$ 24.80
